Related Experiment Video
Updated: Jun 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the
Juan F Delgado1, María G Crespo-Leiro, Miguel A Gómez-Sánchez
1Hospital Universitario 12 De Octubre, Madrid, Spain. jdelgado.hdoc@salud.madrid.org
Insights
Longer survival after heart transplantation (HT) increases risk for chronic kidney disease (CKD). Female sex, higher creatinine levels, older age at transplant, longer time since transplant, and cyclosporine use are identified risk factors for CKD in HT patients.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Long-term survival following heart transplantation (HT) is associated with an increased incidence of calcineurin inhibitor-related chronic kidney disease (CKD).
- Identifying risk factors for CKD in HT recipients is crucial for patient management and improving long-term outcomes.
Purpose of the Study:
- To identify independent risk factors for moderate-to-severe renal dysfunction (MSRD), defined as K/DOQI stage 3 CKD or worse, in adult heart transplant recipients.
Main Methods:
- A cohort of 1062 adult HT patients from 14 Spanish centers was analyzed.
- Glomerular filtration rate (GFR) was estimated using the MDRD equation.
- Multivariate logistic regression was employed to identify predictors of MSRD.
Main Results:
- Over 60% of patients exhibited MSRD at a mean follow-up of 6.7 years post-transplant.
- Independent predictors of MSRD included male sex (protective), higher pre- and post-transplant creatinine, older age at transplant, longer time since transplant, and tacrolimus use (protective).
- Conversely, female sex, higher creatinine, older age, longer time since transplant, and cyclosporine use were identified as risk factors for CKD stage 3 or worse.
Conclusions:
- Female sex, elevated serum creatinine, older age at transplant, longer duration post-transplant, and immunosuppression with cyclosporine are significant risk factors for developing CKD stage 3 or worse in heart transplant recipients.
- These findings highlight the importance of monitoring renal function and considering alternative immunosuppressive strategies in at-risk HT patients.
Abstract:
The longer survival of patients with heart transplantation (HT) favors calcineurin inhibitor-related chronic kidney disease (CKD). It behoves to identify risk factors. At 14 Spanish centers, data on 1062 adult patients with HT (age 59.2 ± 12.3 yr, 82.5% men) were collected at routine follow-up examinations. Glomerular filtration rate, GFR, was estimated using the four-variable MDRD equation, and moderate-or-severe renal dysfunction (MSRD) was defined as K/DOQI stage 3 CKD or worse. Time since transplant ranged from one month to 22 yr (mean 6.7 yr). At assessment, 26.6% of patients were diabetic and 63.9% hypertensive; 53.9% were taking cyclosporine and 33.1% tacrolimus; and 61.4% had MSRD. Among patients on cyclosporine or tacrolimus at assessment, multivariate logistic regression identified male sex (OR 0.44), pre- and post-HT creatinine (2.73 and 3.13 per mg/dL), age at transplant (1.06 per yr), time since transplant (1.05 per yr), and tacrolimus (0.65) as independent positive or negative predictors of MSRD. It is concluded that female sex, pre- and one-month post-HT serum creatinine, age at transplant, time since transplant, and immunosuppression with cyclosporine rather than tacrolimus may all be risk factors for development of CKD ≥ stage 3 by patients with HT.
Related Concept Videos
Kidney Transplant I: Introduction
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Heart Failure Drugs: Diuretics
Acute Kidney Injury II: Pathophysiology